TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1

Q4 2019 Portfolio Holders as of 12/31/2019

Type / Class
Debt / NOTE 2.500% 9/1
Number of holders
32
Total Principal
236M
Shares change
+561K
Total reported value, excl. options
$169M
Value change
+$881K
Put/Call ratio
0
Number of buys
7
Number of sells
-7
Price
$0.78
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.